Call us now :08071793621
Send Inquiry
Send InquiryPegasta Injection
Pegasta Injection Specification
- Salt Composition
- Pegfilgrastim
- Pacakaging (Quantity Per Box)
- 1 pre-filled syringe
- Origin of Medicine
- Biological
- Drug Type
- Injection
- Ingredients
- Pegfilgrastim
- Physical Form
- Liquid
- Function
- Recommended For
- Patients undergoing chemotherapy
- Dosage
- As prescribed by a medical professional
- Dosage Guidelines
- Administered as a subcutaneous injection under healthcare supervision
- Suitable For
- Adults
- Quantity
- Single-use pre-filled syringe
- Storage Instructions
- Store in a refrigerator (28C). Do not freeze. Protect from light.
About Pegasta Injection
The Pegasta Injection is a biological medicine suitable for adults undergoing chemotherapy. It comes in the form of a single-use pre-filled syringe containing Pegfilgrastim, which stimulates white blood cell production to reduce the risk of infections during cancer treatment. Recommended by healthcare professionals, this liquid drug is administered subcutaneously. Stored in the refrigerator between 2-8C, it should be shielded from light to maintain its efficacy, with each pack containing one syringe.
FAQs of Pegasta Injection:
Q: Who is the Pegasta Injection suitable for?
A: The Pegasta Injection is suitable for adults undergoing chemotherapy.Q: What is the function of Pegasta Injection?
A: Pegasta Injection stimulates white blood cell production and reduces the risk of infections during chemotherapy.Q: How should Pegasta Injection be stored?
A: Pegasta Injection should be stored in a refrigerator between 2-8C, protected from light.Q: How is Pegasta Injection administered?
A: Pegasta Injection is administered as a subcutaneous injection under healthcare supervision.Q: What is the composition of Pegasta Injection?
A: Pegasta Injection contains Pegfilgrastim as its salt composition.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Blood Disorder Category
Leuget 50 mg Injection
Drug Type : Injection
Storage Instructions : Store in a refrigerator (2C to 8C); do not freeze
Dosage Guidelines : Administer as directed by the physician; typically through subcutaneous or intramuscular injection
Physical Form : Liquid
Ingredients : Leuprolide acetate
Dosage : 50 mg per injection
Zometa RTU 4 mg Injection
Drug Type : Injection
Storage Instructions : Store at 2C to 8C protect from light do not freeze
Dosage Guidelines : Administered intravenously as directed by a healthcare professional
Physical Form : Liquid
Ingredients : Zoledronic acid
Dosage : 4 mg
Factocel VIII 250 IU Injection
Drug Type : Injection
Storage Instructions : Store in a refrigerator at 2C to 8C; do not freeze. Protect from light
Dosage Guidelines : To be administered intravenously under the supervision of a healthcare professional
Physical Form : Liquid
Ingredients : Factor VIII Concentrate
Dosage : As prescribed by the healthcare provider based on the patients condition
Neovorin 15 mg Injection
Drug Type : Injection
Storage Instructions : Store in a cool and dry place away from direct sunlight
Dosage Guidelines : Administered intravenously or intramuscularly under medical supervision
Physical Form : Liquid
Ingredients : Leucovorin Calcium
Dosage : 15 mg
Send InquiryOur Products
- Alzheimers
- Anti-Cancer
- Anti-Fungal
- Anti-Viral
- Arthritis
- Blood Disorder
- Bone Disease
- Bone Marrow Disorder
- Bowel Disease
- Critical Care
- Gynaecology
- Liver Disease
- Lung Disease
- Macular Degeneration
- Multiple Sclerosis
- Nausea
- Nephrology
- Organ Transplant
- Orthostatic Hypotension
- Osteoporsis
- Psoriasis
- Skin Disorder
- Vaccines
- Pharmaceutical Injection
- Enoxaparin Sodium Medicine
- Oral Suspension
- Pharmaceutical Tablets
- Allopathic Medicine
229, Metro Mall, Bapa Sitaram Chowk, Opp. RAF Camp, S.P. Ring Road, Vastral, Ahmedabad - 382418, Gujarat, India
Dr. Harsh M Patel
(Director)
Mobile :08071793621
Send Inquiry
Send SMS
Developed and Managed by Infocom Network Private Limited.
